New! Sign up for our free email newsletter.
Science News
from research organizations

Immune cells play key role in early breast cancer metastasis even before a tumor develops

Date:
January 2, 2018
Source:
The Mount Sinai Hospital / Mount Sinai School of Medicine
Summary:
Researchers have discovered that normal immune cells called macrophages, which reside in healthy breast tissue surrounding milk ducts, play a major role in helping early breast cancer cells leave the breast for other parts of the body, potentially creating metastasis before a tumor has even developed, according to a new study.
Share:
FULL STORY

Mount Sinai researchers have discovered that normal immune cells called macrophages, which reside in healthy breast tissue surrounding milk ducts, play a major role in helping early breast cancer cells leave the breast for other parts of the body, potentially creating metastasis before a tumor has even developed, according to a study published in Nature Communications.

The macrophages play a role in mammary gland development by regulating how milk ducts branch out through breast tissue. Many studies have also proven the importance of macrophages in metastasis, but until now, only in models of advanced large tumors. By studying human samples, mouse tissues, and breast organoids, which are miniaturized and simplified versions of breast tissue produced in the lab, the new research found that in very early cancer lesions, macrophages are attracted to enter the breast ducts where they trigger a chain reaction that brings early cancer cells out of the breast, said lead researcher Julio Aguirre-Ghiso, PhD, Professor of Oncological Sciences, Otolaryngology, Medicine, Hematology and Medical Oncology at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai.

This research shows that macrophages' relationship with normal breast cells is co-opted by early cancer cells that activate the cancer-causing HER2 gene, helping in this newly-discovered role of these immune cells. The findings from this study could eventually help pinpoint biomarkers to identify cancer patients who may be at risk of carrying potential metastatic cells due to these macrophages and potentially lead to the development of novel therapies that prevent early cancer metastasis.

Early treatment of high-risk patients may prevent the formation of deadly metastasis better than the current standard of treating metastatic disease only once it has occurred, said key researcher Miriam Merad, MD, PhD, Director of the Precision Immunology Institute and the Human Immune Monitoring Center and co-leader of the Cancer Immunology program at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai.

"Our study challenges the dogma that early diagnosis and treatment means sure cure," Dr. Aguirre-Ghiso said. "In this study and in our previous studies, we present mechanisms governing early dissemination. This work further sheds light onto the mysterious process of early dissemination and cancer of an unknown primary tumor."

Researchers hope to build on this study by identifying which macrophages specifically control early dissemination. They also hope to further detail how early disseminated cancer cells interact with macrophages in the lungs where metastases eventually form and how this interaction can be targeted to prevent metastasis.

"Here, we have identified how macrophages and early cancer cells form a 'microenvironment of early dissemination' and show that by disrupting this interaction we can prevent early dissemination and ultimately deadly metastasis," said Dr. Merad. "This sheds light onto the mysterious process of early dissemination and for patients who have metastasis cancer that came from an unknown source."


Story Source:

Materials provided by The Mount Sinai Hospital / Mount Sinai School of Medicine. Note: Content may be edited for style and length.


Journal Reference:

  1. Nina Linde, Maria Casanova-Acebes, Maria Soledad Sosa, Arthur Mortha, Adeeb Rahman, Eduardo Farias, Kathryn Harper, Ethan Tardio, Ivan Reyes Torres, Joan Jones, John Condeelis, Miriam Merad, Julio A. Aguirre-Ghiso. Macrophages orchestrate breast cancer early dissemination and metastasis. Nature Communications, 2018; 9 (1) DOI: 10.1038/s41467-017-02481-5

Cite This Page:

The Mount Sinai Hospital / Mount Sinai School of Medicine. "Immune cells play key role in early breast cancer metastasis even before a tumor develops." ScienceDaily. ScienceDaily, 2 January 2018. <www.sciencedaily.com/releases/2018/01/180102103323.htm>.
The Mount Sinai Hospital / Mount Sinai School of Medicine. (2018, January 2). Immune cells play key role in early breast cancer metastasis even before a tumor develops. ScienceDaily. Retrieved December 21, 2024 from www.sciencedaily.com/releases/2018/01/180102103323.htm
The Mount Sinai Hospital / Mount Sinai School of Medicine. "Immune cells play key role in early breast cancer metastasis even before a tumor develops." ScienceDaily. www.sciencedaily.com/releases/2018/01/180102103323.htm (accessed December 21, 2024).

Explore More

from ScienceDaily

RELATED STORIES